Agonistic antibodies to costimulatory molecules, OX40 and GITR, significantly enhance the antitumor efficacy of Listeria monocytogenes (Lm-LLO)-based immunotherapy

Mikayel Mkrtichyan, Rajeev Shrimali, Rasha Abu Eid, Zuzana Berrong, Anu Wallecha, Robert Petit, Samir N Khleif, Shamim Ahmad

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationCancer Research
PublisherAmerican Association for Cancer Research Inc.
Volume75
Edition15 Supp
DOIs
Publication statusPublished - 1 Aug 2015

Publication series

NameProceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015
PublisherAmerican Association of Cancer Research
ISSN (Print)0008-5472
ISSN (Electronic)1538-7445

Cite this

Mkrtichyan, M., Shrimali, R., Abu Eid, R., Berrong, Z., Wallecha, A., Petit, R., Khleif, S. N., & Ahmad, S. (2015). Agonistic antibodies to costimulatory molecules, OX40 and GITR, significantly enhance the antitumor efficacy of Listeria monocytogenes (Lm-LLO)-based immunotherapy. In Cancer Research (15 Supp ed., Vol. 75). [LB-229] (Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015). American Association for Cancer Research Inc.. https://doi.org/10.1158/1538-7445.AM2015-LB-229